Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction

• Status: Terminated
• Trial end date: 2013-04-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to assess the safety & efficacy of a single dose of alprostadil cream with 2 concentrations of WC3036 compared to vehicle alone in men with erectile dysfunction.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Warner Chilcott
• Treatments: Alprostadil

Criteria

Inclusion Criteria:

• Male subject aged 40 or older of any race

• History of ED (erectile dysfunction) of at least 3 months duration defined as inability to attain & maintain an erection of the penis sufficient to permit satisfactory sexual intercourse

• Completed and signed informed consent prior to any study related procedures

Exclusion Criteria:

• History/presence any significant disease that Investigator feels will interfere with course of the study

• Anatomic deformity of penis

• History/presence alcoholism or drug abuse/dependence within past 2 years (discretion of Investigator)

• Participation in investigational study drug trial within 30 days prior to randomization